Saul Faust to Adolescent
This is a "connection" page, showing publications Saul Faust has written about Adolescent.
Connection Strength
0.136
-
It's Time to Put Children and Young People First During the Global COVID-19 Pandemic. JAMA Pediatr. 2021 02 01; 175(2):127-128.
Score: 0.026
-
COVID-19 in children: current evidence and key questions. Curr Opin Infect Dis. 2020 12; 33(6):540-547.
Score: 0.025
-
The Impact of Pediatric Outpatient Parenteral Antibiotic Therapy Implementation at a Tertiary Children's Hospital in the United Kingdom. Pediatr Infect Dis J. 2018 12; 37(12):e292-e297.
Score: 0.022
-
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet. 2021 04 10; 397(10282):1351-1362.
Score: 0.006
-
COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study. BMJ Open. 2021 03 17; 11(3):e044899.
Score: 0.006
-
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 03 06; 397(10277):881-891.
Score: 0.006
-
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 01 09; 397(10269):99-111.
Score: 0.006
-
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2021 12 19; 396(10267):1979-1993.
Score: 0.006
-
Meningococcal B Vaccine Immunogenicity in Children With Defects in Complement and Splenic Function. Pediatrics. 2018 09; 142(3).
Score: 0.005
-
Ecology and diversity in upper respiratory tract microbial population structures from a cross-sectional community swabbing study. J Med Microbiol. 2018 Aug; 67(8):1096-1108.
Score: 0.005
-
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase d Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase d Syndrome Registry. Front Immunol. 2018; 9:543.
Score: 0.005
-
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP. Sci Rep. 2018 02 21; 8(1):3390.
Score: 0.005
-
Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation. Acta Obstet Gynecol Scand. 2018 Mar; 97(3):330-340.
Score: 0.005
-
Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis. Mol Ther. 2017 09 06; 25(9):2104-2116.
Score: 0.005